Sarcomatoid Adrenal Carcinoma: Case Report with Contribution to Pathogenesis

Area of Science:

• Oncology
• Pathology
• Genetics

Background:

• Initial diagnosis of adrenal region tumor with liver metastases was poorly differentiated sarcoma based on immunohistochemistry.
• The study aimed to re-evaluate the diagnosis using molecular methods in the context of adrenal sarcoma research.

Observation:

• Extensive immunostainings initially suggested sarcoma (vimentin, desmin, myogenin, CD31 positive; inhibin, melan A negative).
• Molecular analysis revealed no MDM-2 gene amplification or FKHR translocation, excluding a sarcoma diagnosis.
• Additional immunostainings identified areas of more mature tumor tissue expressing synaptophysin, SF-1, and melan A.

Findings:

• The tumor was reclassified as sarcomatoid adrenal carcinoma, a rare subtype of adrenal cortical cancer with dedifferentiation.
• This diagnosis integrates findings of both adrenal cortical and sarcomatous elements.

Implications:

• Highlights the importance of molecular diagnostics in refining cancer classifications.
• Emphasizes the existence and characteristics of rare adrenal malignancies like sarcomatoid adrenal carcinoma.
• Suggests potential for complex tumor biology and diagnostic challenges in adrenal neoplasms.